MEDP
Medpace Holdings, Inc.
Platform & Compounding FCF
A+
94.8 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
40.2%
-
Operating Margin Trend
+0.96 pp/yr
-
5yr Avg ROE
56.1%
-
5yr Share-Count CAGR
-4.8%
-
5yr Revenue CAGR
22.3%
-
5yr EPS CAGR
31.8%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
23.9%
-
5yr FCF/NI Conversion
1.41x
-
Net Debt / EBITDA
-0.43x
-
Interest Coverage (EBIT/Int)
30.00x
-
Altman Z-Score
8.45
Stability
Weight: 5%
C-
48
-
EPS Volatility (σ/μ)
0.86
-
Negative-Revenue Years (5)
0/5
-
Piotroski F-Score
6
4 of 4 gurus held; 1 added; 3 trimmed.
- Holders
- 4
- Avg Δ position
-
-19.2%
- New buys
- 0
- Full exits
- 0